These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 18679167

  • 1. Carbohydrate and lipid metabolism following infliximab therapy in pediatric Crohn's disease.
    Steiner SJ, Pfefferkorn MD, Fitzgerald JF, Denne SC.
    Pediatr Res; 2008 Dec; 64(6):673-6. PubMed ID: 18679167
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of infliximab and parenteral nutrition on albumin and fibrinogen synthesis rates in pediatric Crohn disease.
    Steiner SJ, Pfefferkorn MD, Fitzgerald JF, Denne SC.
    J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):579-84. PubMed ID: 18979581
    [Abstract] [Full Text] [Related]

  • 5. Energy and substrate metabolism in patients with active Crohn's disease.
    Schneeweiss B, Lochs H, Zauner C, Fischer M, Wyatt J, Maier-Dobersberger T, Schneider B.
    J Nutr; 1999 Apr; 129(4):844-8. PubMed ID: 10203559
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Energy metabolism and substrate oxidation in patients with Crohn's disease.
    Al-Jaouni R, Hébuterne X, Pouget I, Rampal P.
    Nutrition; 2000 Mar; 16(3):173-8. PubMed ID: 10705071
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
    Absah I, Faubion WA.
    Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301
    [Abstract] [Full Text] [Related]

  • 12. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone.
    Azcue M, Rashid M, Griffiths A, Pencharz PB.
    Gut; 1997 Aug; 41(2):203-8. PubMed ID: 9301499
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunomodulators and "on demand" therapy with infliximab in Crohn's disease: clinical experience with 400 infusions.
    Kinney T, Rawlins M, Kozarek R, France R, Patterson D.
    Am J Gastroenterol; 2003 Mar; 98(3):608-12. PubMed ID: 12650795
    [Abstract] [Full Text] [Related]

  • 15. [Anti-TNF therapy in treatment of luminal Crohn's disease].
    Marko B, Prka L.
    Acta Med Croatica; 2013 Apr; 67(2):179-89. PubMed ID: 24471301
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [A case of psoriasis induced by infliximab treatment for Crohn's disease].
    Jwa YJ, Kim NH, Park HJ, Park JS, Bae WK, Kim KA, Lee JS, Moon YS.
    Korean J Gastroenterol; 2010 Nov; 56(5):324-8. PubMed ID: 21099241
    [Abstract] [Full Text] [Related]

  • 20. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
    Rozpondek P, Zwolińska-Wcisło M, Przybylska M, Mach T.
    Przegl Lek; 2011 Nov; 68(9):602-5. PubMed ID: 22335009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.